175 related articles for article (PubMed ID: 16163542)
1. Twelve years experience of juvenile dermatomyositis in North India.
Singh S; Bansal A
Rheumatol Int; 2006 Apr; 26(6):510-5. PubMed ID: 16163542
[TBL] [Abstract][Full Text] [Related]
2. Aggressive management of juvenile dermatomyositis results in improved outcome and decreased incidence of calcinosis.
Fisler RE; Liang MG; Fuhlbrigge RC; Yalcindag A; Sundel RP
J Am Acad Dermatol; 2002 Oct; 47(4):505-11. PubMed ID: 12271292
[TBL] [Abstract][Full Text] [Related]
3. Juvenile dermatomyositis: clinical profile and disease course in 25 patients.
Shehata R; al-Mayouf S; al-Dalaan A; al-Mazaid A; al-Balaa S; Bahabri S
Clin Exp Rheumatol; 1999; 17(1):115-8. PubMed ID: 10084045
[TBL] [Abstract][Full Text] [Related]
4. Juvenile dermatomyositis in Thai children: Retrospective review of 30 cases from a tertiary care center.
Nitiyarom R; Charuvanij S; Likasitwattanakul S; Thanoophunchai C; Wisuthsarewong W
Indian J Dermatol Venereol Leprol; 2022; 88(2):162-170. PubMed ID: 34491668
[TBL] [Abstract][Full Text] [Related]
5. Complete and sustained remission of juvenile dermatomyositis resulting from aggressive treatment.
Kim S; El-Hallak M; Dedeoglu F; Zurakowski D; Fuhlbrigge RC; Sundel RP
Arthritis Rheum; 2009 Jun; 60(6):1825-1830. PubMed ID: 19479872
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate.
Al-Mayouf S; Al-Mazyed A; Bahabri S
Clin Rheumatol; 2000; 19(2):138-41. PubMed ID: 10791626
[TBL] [Abstract][Full Text] [Related]
7. Ten-year experience of juvenile dermatomyositis: a retrospective study.
Chiu SK; Yang YH; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2007 Feb; 40(1):68-73. PubMed ID: 17332910
[TBL] [Abstract][Full Text] [Related]
8. Course of treated juvenile dermatomyositis.
Spencer CH; Hanson V; Singsen BH; Bernstein BH; Kornreich HK; King KK
J Pediatr; 1984 Sep; 105(3):399-408. PubMed ID: 6470862
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features of patients with juvenile and adult dermatomyositis].
Szalmás O; Nagy-Vince M; Dankó K; Farkas F
Orv Hetil; 2015 Sep; 156(37):1491-6. PubMed ID: 26552025
[TBL] [Abstract][Full Text] [Related]
10. Disease patterns of juvenile dermatomyositis from Western India.
Chickermane PR; Mankad D; Khubchandani RP
Indian Pediatr; 2013 Oct; 50(10):961-3. PubMed ID: 23798628
[TBL] [Abstract][Full Text] [Related]
11. Favorable outcomes with reduced steroid use in juvenile dermatomyositis.
Orandi AB; Fotis L; Lai J; Morris H; White AJ; French AR; Baszis KW
Pediatr Rheumatol Online J; 2021 Aug; 19(1):127. PubMed ID: 34404425
[TBL] [Abstract][Full Text] [Related]
12. Outcome in juvenile dermatomyositis.
Chowdhary V; Wakhlu A; Agarwal A; Misra R
Indian Pediatr; 2002 Oct; 39(10):931-5. PubMed ID: 12428038
[TBL] [Abstract][Full Text] [Related]
13. Juvenile dermatomyositis: clinical, laboratorial, histological, therapeutical and evolutive parameters of 35 patients.
Sallum AM; Kiss MH; Sachetti S; Resende MB; Moutinho KC; Carvalho Mde S; Silva CA; Marie SK
Arq Neuropsiquiatr; 2002 Dec; 60(4):889-99. PubMed ID: 12563375
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome in children with juvenile dermatomyositis: A single-center study from north India.
Sharma A; Gupta A; Rawat A; Suri D; Singh S
Int J Rheum Dis; 2020 Mar; 23(3):392-396. PubMed ID: 31793219
[TBL] [Abstract][Full Text] [Related]
15. Skin disease is more recalcitrant than muscle disease: A long-term prospective study of 184 children with juvenile dermatomyositis.
Wang A; Morgan GA; Paller AS; Pachman LM
J Am Acad Dermatol; 2021 Jun; 84(6):1610-1618. PubMed ID: 33359787
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling.
Deakin CT; Campanilho-Marques R; Simou S; Moraitis E; Wedderburn LR; Pullenayegum E; Pilkington CA;
Arthritis Rheumatol; 2018 May; 70(5):785-793. PubMed ID: 29342499
[TBL] [Abstract][Full Text] [Related]
17. Juvenile dermatomyositis and polymyositis: a follow-up study of long-term sequelae.
Collison CH; Sinal SH; Jorizzo JL; Walker FO; Monu JU; Snyder J
South Med J; 1998 Jan; 91(1):17-22. PubMed ID: 9438396
[TBL] [Abstract][Full Text] [Related]
18. An extremely severe case of cutaneous calcinosis complicating adult dermatomyositis.
Kavala M; Sudogan S; Can B; Zindanci I; Kuru I; Beyhan S; Kocaturk E
Clin Exp Dermatol; 2009 Jan; 34(1):115-6. PubMed ID: 19076816
[No Abstract] [Full Text] [Related]
19. Juvenile dermatomyositis: a tertiary center experience.
Barut K; Aydin PO; Adrovic A; Sahin S; Kasapcopur O
Clin Rheumatol; 2017 Feb; 36(2):361-366. PubMed ID: 28058540
[TBL] [Abstract][Full Text] [Related]
20. Juvenile dermatomyositis.
Halbert AR
Australas J Dermatol; 1996 May; 37(2):106-8. PubMed ID: 8687325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
